An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer

Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study

(2018) Siamak Daneshmand et al.   JOURNAL OF UROLOGY

Evolution of technologies in urology: full steam ahead?

(2018) Nathan Lawrentschuk   WORLD JOURNAL OF UROLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study

(2017) Renate Pichler et al.   International Journal of Medical Sciences

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

(2017) Laimonis Kavalieris et al.   JOURNAL OF UROLOGY

FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

(2017) Willemien Beukers et al.   JOURNAL OF UROLOGY

Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer

(2017) Nitu Kumari et al.   TUMOR BIOLOGY

Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma

(2017) Yair Lotan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer

(2016) Jean-Pierre Roperch et al.   BMC CANCER

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

(2016) Ashish M. Kamat et al.   EUROPEAN UROLOGY

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

Biomarkers for precision medicine in bladder cancer

(2016) Takahiro Kojima et al.   International Journal of Clinical Oncology

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

(2016) Sam S. Chang et al.   JOURNAL OF UROLOGY

Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer

(2016) Aurélie Mbeutcha et al.   UROLOGIC CLINICS OF NORTH AMERICA

Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study

(2016) Michael D. Bell et al.   WORLD JOURNAL OF UROLOGY

Novel fluorescencein situhybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies

(2015) Ashish M. Kamat et al.   BJU INTERNATIONAL

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer

(2015) Faysal A. Yafi et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine

(2015) Leonel Maldonado et al.   Oncotarget

A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence

(2014) S.-F. Su et al.   CLINICAL CANCER RESEARCH

The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer-institutional experience and review

(2014) Binnur Önal et al.   DIAGNOSTIC CYTOPATHOLOGY

Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer

(2014) G Mowatt et al.   HEALTH TECHNOLOGY ASSESSMENT

The mechanism of action of BCG therapy for bladder cancer—a current perspective

(2014) Gil Redelman-Sidi et al.   Nature Reviews Urology

Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?

(2014) Casey Seideman et al.   WORLD JOURNAL OF UROLOGY

Reflex fluorescencein situhybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy

(2013) Philip H. Kim et al.   BJU INTERNATIONAL

A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine

(2013) R. Kandimalla et al.   CLINICAL CANCER RESEARCH

Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial Carcinoma

(2013) Bishoy A. Gayed et al.   JOURNAL OF UROLOGY

Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study

(2013) Huixiang Yang et al.   UROLOGIA INTERNATIONALIS

Clinical performance and utility of a DNA methylation urine test for bladder cancer11This study was funded, in part, by MDxHealth (formerly OncoMethlyome Sciences).

(2013) Michael R. Abern et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers

(2012) Ashish M. Kamat et al.   EUROPEAN UROLOGY

In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors

(2012) Enis Coskuner et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

(2012) TOMMASO CAI et al.   Experimental and Therapeutic Medicine

Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma

(2011) Jamie Messer et al.   BJU INTERNATIONAL

Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology

(2011) Shahrokh F. Shariat et al.   CANCER

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

(2011) Derya Tilki et al.   EUROPEAN UROLOGY

Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study

(2011) Eugene K. Cha et al.   EUROPEAN UROLOGY

Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder

(2010) Hans-Martin Fritsche et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts

(2010) Anne Sofie Brems-Eskildsen et al.   BMC CANCER

Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer

(2010) T. C. M. Zuiverloon et al.   CLINICAL CANCER RESEARCH

Statistical consideration for clinical biomarker research in bladder cancer

(2010) Shahrokh F. Shariat et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

(2010) Yair Lotan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology

(2010) Ramy F. Youssef et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Use of the NMP22 BladderChek Test in the Diagnosis and Follow-Up of Urothelial Cancer: A Cross-sectional Study

(2010) Eu Chang Hwang et al.   UROLOGY

Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma

(2009) Peggy S. Sullivan et al.   CANCER CYTOPATHOLOGY

Predictive Value of Urinary Interleukin-8 Cutoff Point for Recurrences After Transurethral Resection Plus Induction Bacillus Calmette-Guérin Treatment in Non–Muscle-Invasive Bladder Tumors

(2009) Levent Sagnak et al.   Clinical Genitourinary Cancer

HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer

(2009) Mario W. Kramer et al.   EUROPEAN UROLOGY

The prognostic value of cytology and fluorescencein situhybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

(2009) Spasenija Savic et al.   INTERNATIONAL JOURNAL OF CANCER

Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder

(2009) Bruce J. Schlomer et al.   JOURNAL OF UROLOGY

Combinations of urine-based tumour markers in bladder cancer surveillance

(2009) Marcus Horstmann et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder

(2009) Narmada P. Gupta et al.   UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22

(2008) Rupesh Raina et al.   BJU INTERNATIONAL

Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])

(2008) Madelon N.M. van der Aa et al.   EUROPEAN UROLOGY

The Molecular Signature for Urothelial Carcinoma of the Upper Urinary Tract

(2008) Chung-Liang Ho et al.   JOURNAL OF UROLOGY

Prospective Evaluation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder

(2008) Yair Lotan et al.   JOURNAL OF UROLOGY

Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma

(2008) M. Babjuk et al.   UROLOGY

The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies

(2008) Mika-P. Raitanen et al.   WORLD JOURNAL OF UROLOGY

The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer

(2007) Sigurdur Gudjónsson et al.   EUROPEAN UROLOGY